Case number 2017-1357
Supernus Pharmaceuticals, Inc. v. Iancu > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | SUPERNUS PHARMACEUTICALS, INC. v. IANCU [OPINION - PRECEDENTIAL] [precedential] (0) |
| Mar 18, 2019 | 48 | Mandate issued to the United States District Court for the Eastern District of Virginia. Service as of this date by the Clerk of Court. [593607] [JAB] [Entered: 03/18/2019 02:29 PM] (2) |
| Jan 23, 2019 | 47 | JUDGMENT filed. REVERSED AND REMANDED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [580047] [PBC] [Entered: 01/23/2019 09:56 AM] (2) |
| Jan 23, 2019 | 46 | OPINION filed for the court by Dyk, Circuit Judge; Schall, Circuit Judge and Reyna, Circuit Judge. Precedential Opinion. [580046] [PBC] [Entered: 01/23/2019 09:55 AM] (19) |
| Feb 8, 2018 | 45 | Official caption revised - the official caption in this matter is revised to substitute Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, as appellee. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [496233] [JAB] [Entered: 02/08/2018 12:14 PM] (0) |
| Dec 4, 2017 | 44 | Submitted after ORAL ARGUMENT by Douglas H. Carsten for Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation and R. Trent McCotter for Joseph Matal. Panel: Judge: Dyk, Judge: Schall, Judge: Reyna. [479916] [SJ] [Entered: 12/04/2017 01:26 PM] (0) |
| Oct 27, 2017 | 43 | Response to oral argument order from the Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. designating Douglas H. Carsten as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [471102] [Douglas Carsten] [Entered: 10/27/2017 01:35 PM] (0) |
| Oct 26, 2017 | 42 | Response to oral argument order from the Appellee Joseph Matal. designating R. Trent McCotter as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [470771] [R. Trent McCotter] [Entered: 10/26/2017 11:31 AM] (0) |
| Oct 26, 2017 | 41 | Entry of appearance for R. Trent McCotter as principal counsel for Appellee Joseph Matal. Service: 10/26/2017 by email. [470766] [R. Trent McCotter] [Entered: 10/26/2017 11:25 AM] (1) |
| Oct 20, 2017 | 40 | NOTICE OF CALENDARING. Panel: 1712C. Case scheduled Dec 04, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 402. Response to oral argument order due: 11/15/2017. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [469371] [JAB] [Entered: 10/20/2017 11:59 AM] (0) |
| Aug 24, 2017 | 39 | Notice from Appellant United Therapeutics Corporation regarding conflicts with oral argument (November 6-9). Service: 08/24/2017 by email. [456312] [Douglas Carsten] [Entered: 08/24/2017 10:49 AM] (1) |
| Jun 20, 2017 | 38 | Notice from Appellant United Therapeutics Corporation regarding conflicts with oral argument (August 7-11; September 5-8). Service: 06/20/2017 by email. [440896] [Douglas Carsten] [Entered: 06/20/2017 06:05 PM] (1) |
| Jun 19, 2017 | 37 | 6 paper copies of the Joint Appendix [32] received from Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. [440605] [JCP] [Entered: 06/20/2017 06:44 AM] (0) |
| Jun 16, 2017 | 36 | Notice from Appellee Joseph Matal regarding conflicts with oral argument (None). Service: 06/16/2017 by email. [440147] [Antonia Konkoly] [Entered: 06/16/2017 08:02 PM] (1) |
| Jun 16, 2017 | 35 | CORRECTED certificate of service for Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation for Brief , Doc No. [31]. Service: 06/16/2017 by email. [440131] [Douglas Carsten] [Entered: 06/16/2017 05:39 PM] (1) |
| Jun 16, 2017 | 34 | Clerk's Note to the File: After filing the joint appendix the clerk's office noticed that there may be pages missing from the appendix. Please review the appendix and file a notice of correction and corrected version if there are any missing pages. (Ref: [32], [31]) [440008] [JCA] [Entered: 06/16/2017 01:54 PM] (0) |
| Jun 15, 2017 | 33 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks (August 2017, September 2017, October 2017), or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 06/22/2017. [439430] [JCA] [Entered: 06/15/2017 09:57 AM] (0) |
| Jun 14, 2017 | 32 | APPENDIX FILED for Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation [31]. Number of Pages: 467. Service: 06/14/2017 by email. The paper copies of the brief should be received by the court on or before 06/22/2017. [439427] [JCA] [Entered: 06/15/2017 09:54 AM] (467) |
| Jun 14, 2017 | 31 | TENDERED from Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. Title: JOINT APPENDIX. Service: 06/14/2017 by email. [439341] [Douglas Carsten] [Entered: 06/14/2017 06:15 PM] (467) |
| Jun 14, 2017 | 30 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. Service: 06/14/2017 by email. [439340] [Douglas Carsten] [Entered: 06/14/2017 06:11 PM] (3) |
| Jun 9, 2017 | 29 | 6 paper copies of the Reply Brief [27] received from Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. [437905] [JCP] [Entered: 06/09/2017 01:06 PM] (0) |
| Jun 9, 2017 | 28 | Official caption revised to reflect Joseph Matal, Performing the Functions and Duties of the Under Secretary of Commerce for Intellectual Property and Director, U.S. Patent and Trademark Office. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [437862] [CMP] [Entered: 06/09/2017 12:20 PM] (0) |
| Jun 7, 2017 | 25 | Amended Certificate of Interest for the Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. Service: 06/07/2017 by email. [437317] [Douglas Carsten] [Entered: 06/07/2017 04:57 PM] (3) |
| Jun 7, 2017 | 26 | TENDERED from Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. Title: REPLY BRIEF. Service: 06/07/2017 by email. [437337] [Douglas Carsten] [Entered: 06/07/2017 06:59 PM] (36) |
| Jun 7, 2017 | 27 | REPLY BRIEF FILED for Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation [26]. Number of Pages: 29. Service: 06/07/2017 by email. The paper copies of the brief should be received by the court on or before 06/15/2017. Appendix is due 06/14/2017. [437393] [CAB] [Entered: 06/08/2017 09:15 AM] (36) |
| May 15, 2017 | 24 | 6 paper copies of the Corrected Response Brief [23] received from Appellee Lee. [431428] [KW] [Entered: 05/15/2017 02:32 PM] (0) |
| May 11, 2017 | 23 | CORRECTED BRIEF FILED for Appellee Lee [22]. Number of Pages: 57. Service: 05/11/2017 by email. The paper copies of the brief should be received by the court on or before 05/18/2017. [430766] [MJL] [Entered: 05/11/2017 03:02 PM] (70) |
| May 11, 2017 | 22 | TENDERED from Appellee Lee. Title: CORRECTED RESPONSE BRIEF. Service: 05/11/2017 by email. [430596] [Antonia Konkoly] [Entered: 05/11/2017 11:47 AM] (70) |
| May 11, 2017 | 21 | NOTICE OF REJECTION: The brief of Appellee Lee [20] is not in compliance with the rules of this court and is therefore rejected for filing. Corrected brief due 05/25/2017. Service as of this date by Clerk of Court. [430535] [MJL] [Entered: 05/11/2017 10:26 AM] (2) |
| May 10, 2017 | 20 | TENDERED from Appellee Lee. Title: RESPONSE BRIEF. Service: 05/10/2017 by email. [430462]. This brief has been rejected. See Doc. No. [21]. [Antonia Konkoly] [Entered: 05/10/2017 07:13 PM] (0) |
| Mar 22, 2017 | 19 | ORDER filed. The motion [18] is granted. The appellee's response brief is due May 10, 2017 and the appellants' reply brief is due June 7, 2017. Service: 03/22/2017 by clerk. [418034] [LMS] [Entered: 03/22/2017 03:39 PM] (2) |
| Mar 15, 2017 | 18 | MOTION of Appellants Supernus Pharmaceuticals, Inc., United Therapeutics Corporation and Appellee Lee to extend the time to 05/10/2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service, to extend the time to 06/07/2017 to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/15/2017 by email. [415765] [Antonia Konkoly] [Entered: 03/15/2017 03:19 PM] (7) |
| Mar 1, 2017 | 17 | 6 paper copies of the Opening Brief [16] received from Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. [412220] [KW] [Entered: 03/03/2017 09:19 AM] (0) |
| Feb 27, 2017 | 16 | BRIEF FILED for Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation [15]. Number of Pages: 59. Service: 02/27/2017 by email. The paper copies of the brief should be received by the court on or before 03/07/2017. Brief of Appellee Michelle K. Lee, Director, U.S. Patent and Trademark Office is due 04/10/2017. [411118] [MJL] [Entered: 02/28/2017 10:49 AM] (104) |
| Feb 27, 2017 | 15 | TENDERED from Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. Title: OPENING BRIEF. Service: 02/27/2017 by email. [411016] [Douglas Carsten] [Entered: 02/27/2017 09:11 PM] (104) |
| Feb 27, 2017 | 14 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [410928] [CMP] [Entered: 02/27/2017 03:26 PM] (0) |
| Feb 7, 2017 | 13 | **TEXT ONLY** ORDER granting motion to extend time to file appellant/petitioner principal brief [12] filed by Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. Brief due 02/27/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [405196] [JB] [Entered: 02/07/2017 12:01 PM] (0) |
| Feb 6, 2017 | 12 | MOTION of Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation to extend the time to 02/27/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/06/2017 by email. [405044] [Douglas Carsten] [Entered: 02/06/2017 07:00 PM] (4) |
| Jan 25, 2017 | 11 | Entry of appearance for Brian Racilla as of counsel for Appellee Lee. Service: 01/25/2017 by email. [402003] [Brian Racilla] [Entered: 01/25/2017 03:36 PM] (2) |
| Jan 25, 2017 | 10 | Entry of appearance for Kakoli Caprihan as of counsel for Appellee Lee. Service: 01/25/2017 by email. [401996] [Kakoli Caprihan] [Entered: 01/25/2017 03:34 PM] (2) |
| Dec 22, 2016 | 9 | Docketing Statement for the Appellee Lee. Service: 12/22/2016 by email. [393799] [Antonia Konkoly] [Entered: 12/22/2016 03:33 PM] (3) |
| Dec 22, 2016 | 8 | Entry of appearance for Antonia Konkoly as principal counsel for Appellee Lee. Service: 12/22/2016 by email. [393797] [Antonia Konkoly] [Entered: 12/22/2016 03:31 PM] (1) |
| Dec 21, 2016 | 7 | Entry of appearance for Adam Burrowbridge as of counsel for Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. Service: 12/21/2016 by email. [393343] [Adam Burrowbridge] [Entered: 12/21/2016 07:03 PM] (2) |
| Dec 21, 2016 | 6 | Entry of appearance for Shaun R. Snader as of counsel for Appellant United Therapeutics Corporation. Service: 12/21/2016 by email. [393342] [Shaun Snader] [Entered: 12/21/2016 06:59 PM] (2) |
| Dec 21, 2016 | 5 | Entry of appearance for Veronica S. Ascarrunz as of counsel for Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. Service: 12/21/2016 by email. [393341] [Veronica Ascarrunz] [Entered: 12/21/2016 06:55 PM] (2) |
| Dec 21, 2016 | 4 | Docketing Statement for the Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. Service: 12/21/2016 by email. [393339] [Douglas Carsten] [Entered: 12/21/2016 06:51 PM] (4) |
| Dec 21, 2016 | 3 | Certificate of Interest for the Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. Service: 12/21/2016 by email. [393338] [Douglas Carsten] [Entered: 12/21/2016 06:49 PM] (2) |
| Dec 21, 2016 | 2 | Entry of appearance for Douglas H. Carsten as principal counsel for Appellants Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation. Service: 12/21/2016 by email. [393337] [Douglas Carsten] [Entered: 12/21/2016 06:48 PM] (2) |
| Dec 14, 2016 | 1 | Appeal docketed. Received: 12/09/2016. [390902]Entry of Appearance due 12/28/2016. Certificate of Interest is due on 12/28/2016. Docketing Statement due 01/13/2017. Appellant/Petitioner's brief is due 02/13/2017. [CMP] [Entered: 12/14/2016 11:38 AM] (28) |
